Results 291 to 300 of about 10,254,505 (350)
Some of the next articles are maybe not open access.
Advanced Healthcare Materials, 2019
The advantages of fluorescence bioimaging in the second near‐infrared (NIR II, 1000–1700 nm) window are well known; however, current NIR II fluorescent probes for in vivo tumor imaging still have many shortcomings, such as low fluorescence efficiency ...
Jing-jing Zhang +7 more
semanticscholar +1 more source
The advantages of fluorescence bioimaging in the second near‐infrared (NIR II, 1000–1700 nm) window are well known; however, current NIR II fluorescent probes for in vivo tumor imaging still have many shortcomings, such as low fluorescence efficiency ...
Jing-jing Zhang +7 more
semanticscholar +1 more source
2003
Radiopharmaceuticals are used to detect and characterise disease processes, or normal biological function, in living cells, animals or humans. Used as tracer molecules, they map the distribution, uptake and metabolism of the molecule in clinical studies, basic research or applied research. The area of radiopharmaceuticals is expanding rapidly.
Hustinx, Roland, Alavi, Abass
openaire +3 more sources
Radiopharmaceuticals are used to detect and characterise disease processes, or normal biological function, in living cells, animals or humans. Used as tracer molecules, they map the distribution, uptake and metabolism of the molecule in clinical studies, basic research or applied research. The area of radiopharmaceuticals is expanding rapidly.
Hustinx, Roland, Alavi, Abass
openaire +3 more sources
Luminescent gold nanoclusters for in vivo tumor imaging.
In Analysis, 2019Fluorescent gold nanoclusters (AuNCs) are emerging as novel imaging contrast agents. These molecules offer excellent prospects for non-invasive tumor diagnosis strategies because of their ultra-small size, tunable emissions from the visible to the near ...
Huili Li, Hongle Li, A. Wan
semanticscholar +1 more source
Journal of Drug Delivery Science and Technology, 2019
Cancer is the major burden of disease worldwide. The folate receptor, as a specific tumor target, is over-expressed in many types of cancer including ovarian carcinomas, breast, colon, renal, and lung tumors.
M. Silindir-Gunay +5 more
semanticscholar +1 more source
Cancer is the major burden of disease worldwide. The folate receptor, as a specific tumor target, is over-expressed in many types of cancer including ovarian carcinomas, breast, colon, renal, and lung tumors.
M. Silindir-Gunay +5 more
semanticscholar +1 more source
Imaging of Neuroendocrine Tumors
Seminars in Nuclear Medicine, 2006Neuroendocrine tumors (NETs) are rare neoplasms, which are characterized by the presence of neuroamine uptake mechanisms and/or peptide receptors at the cell membrane and these features constitute the basis of the clinical use of specific radiolabeled ligands, both for imaging and therapy.
Rufini, Vittoria +2 more
openaire +3 more sources
Erythrocyte-derived vesicles for circulating tumor cell capture and specific tumor imaging.
Nanoscale, 2019The precise diagnosis of cancer remains a great challenge; therefore, it is our research interest to develop safe, tumor-specific reagents. In this study, we designed nanovesicles derived from erythrocyte membranes; the nanovesicles are capable of ...
Ming Chen +11 more
semanticscholar +1 more source
Imaging of Neuroendocrine Tumors
Hematology/Oncology Clinics of North America, 2007Neuroendocrine tumors may arise from a wide range of organs and may occur in various locations in the body. They include carcinoid tumors, paragangliomas (pheochromocytomas), medullary thyroid carcinomas, and islet cell tumors of the pancreas. In this article the authors focus on the more common tumors with origins primarily in the abdomen, namely ...
Eric P, Tamm, E Edmund, Kim, Chaan S, Ng
openaire +2 more sources
Cold Spring Harbor Perspectives in Medicine
Molecular imaging-the mapping of molecular and cellular processes in vivo-has the unique capability to interrogate cancer metabolism in its spatial contexts. This work describes the usage of the two most developed modalities for imaging metabolism in vivo: positron emission tomography (PET) and magnetic resonance (MR).
Thomas, Ruan, Kayvan R, Keshari
openaire +2 more sources
Molecular imaging-the mapping of molecular and cellular processes in vivo-has the unique capability to interrogate cancer metabolism in its spatial contexts. This work describes the usage of the two most developed modalities for imaging metabolism in vivo: positron emission tomography (PET) and magnetic resonance (MR).
Thomas, Ruan, Kayvan R, Keshari
openaire +2 more sources
Peptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy
Advanced Functional Materials, 2018During the last decade, peptide‐based nanomaterials are recognized as upcoming biomedical materials for tumor imaging and therapy. The rapid expansion of peptides and peptide derivatives is almost owing to their excellent biocompatibility, diverse ...
Chi Zhang +6 more
semanticscholar +1 more source
Quantitative Musculoskeletal Tumor Imaging
Seminars in Musculoskeletal Radiology, 2020AbstractThe role of quantitative magnetic resonance imaging (MRI) and positron emission tomography/computed tomography (PET/CT) techniques continues to grow and evolve in the evaluation of musculoskeletal tumors. In this review we discuss the MRI quantitative techniques of volumetric measurement, chemical shift imaging, diffusion-weighted imaging ...
B Matthew, Howe +4 more
openaire +2 more sources